THURMAN RANDY H
Insider CIK 1204059 · MDRX Director · ARNI Director · LENS Executive Chairman, Director · ONS Director · TFFP Director · OFIX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OTLK Outlook Therapeutics, Inc. | P Buy | 2026-05-26 | 2026-05-27 | 5,000 | $0.43 | $2.1K | 5,593 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2025-10-01 | 2025-10-03 | 286,734 | — | $0 | 286,734 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2024-10-01 | 2024-10-03 | 56,636 | — | $0 | 56,636 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2024-10-01 | 2024-10-03 | 89,549 | — | $0 | 89,549 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2024-03-07 | 2024-03-08 | 94,441 | — | $0 | 94,441 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2023-03-29 | 2023-03-31 | 41,065 | — | $0 | 41,065 | SEC↗ |
| TFFP TFF Pharmaceuticals, Inc. | M Exercise deriv | 2022-09-29 | 2022-09-30 | 40,255 | — | $0 | 84,670 | SEC↗ |
| TFFP TFF Pharmaceuticals, Inc. | S Sale | 2022-09-29 | 2022-09-30 | 40,255 | $4.29 | $172.7K | 0 | SEC↗ |
| TFFP TFF Pharmaceuticals, Inc. | M Exercise | 2022-09-29 | 2022-09-30 | 40,255 | $2.50 | $100.6K | 40,255 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2022-03-23 | 2022-03-24 | 81,878 | — | $0 | 81,878 | SEC↗ |
| TFFP TFF Pharmaceuticals, Inc. | P Buy | 2021-05-18 | 2021-05-19 | 1,050 | $9.40 | $9.9K | 1,050 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2021-03-24 | 2021-03-26 | 20,873 | — | $0 | 20,873 | SEC↗ |
| TFFP TFF Pharmaceuticals, Inc. | S Sale | 2020-11-13 | 2020-11-13 | 5,000 | $17.17 | $85.9K | 0 | SEC↗ |
| TFFP TFF Pharmaceuticals, Inc. | M Exercise deriv | 2020-11-11 | 2020-11-13 | 34,504 | — | $0 | 124,925 | SEC↗ |
| TFFP TFF Pharmaceuticals, Inc. | M Exercise | 2020-11-11 | 2020-11-13 | 34,504 | $2.50 | $86.3K | 39,504 | SEC↗ |
| TFFP TFF Pharmaceuticals, Inc. | S Sale | 2020-11-11 | 2020-11-13 | 34,504 | $15.91 | $549.0K | 5,000 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-10-05 | 2020-10-05 | 396,809 | $0.51 | $202.4K | 396,809 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-10-01 | 2020-10-05 | 259,297 | — | $0 | 259,297 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2020-09-14 | 2020-09-15 | 10,000 | $0.62 | $6.2K | 11,875 | SEC↗ |
| TFFP TFF Pharmaceuticals, Inc. | A Award deriv | 2020-08-24 | 2020-08-26 | 20,000 | — | $0 | 159,429 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-07-17 | 2020-07-21 | 210,000 | — | $0 | 210,000 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-07-17 | 2020-09-17 | 154,555 | — | $0 | 154,555 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-03-19 | 2020-03-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TFFP TFF Pharmaceuticals, Inc. | A Award deriv | 2019-11-29 | 2019-12-03 | 3,623 | — | $0 | 139,429 | SEC↗ |
| TFFP TFF Pharmaceuticals, Inc. | A Award deriv | 2019-10-29 | 2019-10-29 | 43,794 | — | $0 | 135,806 | SEC↗ |
| TFFP TFF Pharmaceuticals, Inc. | P Buy | 2019-10-25 | 2019-10-29 | 5,000 | $5.00 | $25.0K | 5,000 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2019-10-03 | 2019-10-07 | 207,036 | $0.99 | $205.0K | 207,036 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2019-10-03 | 2019-10-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2018-12-21 | 2018-12-21 | 15,000 | $0.68 | $10.2K | 15,000 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award deriv | 2018-11-09 | 2018-11-13 | 567,522 | $0.61 | $346.2K | 567,522 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award deriv | 2018-09-21 | 2018-09-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award deriv | 2018-06-27 | 2018-06-28 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award deriv | 2018-04-13 | 2018-04-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MDRX ALLSCRIPTS HEALTHCARE SOLU | A Award | 2017-05-22 | 2017-05-24 | 16,765 | — | $0 | 105,014 | SEC↗ |
| LENS Presbia PLC | A Award | 2017-03-13 | 2017-03-22 | 12,738 | — | $0 | 45,924 | SEC↗ |
| LENS Presbia PLC | X Exercise deriv | 2017-03-08 | 2017-03-10 | 16,533 | — | $0 | 0 | SEC↗ |
| LENS Presbia PLC | X Exercise | 2017-03-08 | 2017-03-10 | 5,543 | $3.00 | $16.6K | 33,186 | SEC↗ |
| LENS Presbia PLC | A Award | 2016-08-05 | 2016-08-09 | 8,247 | — | $0 | 27,643 | SEC↗ |
| MDRX ALLSCRIPTS HEALTHCARE SOLU | A Award | 2016-05-24 | 2016-05-26 | 15,129 | — | $0 | 88,249 | SEC↗ |
| LENS Presbia PLC | P Buy | 2015-11-25 | 2015-11-30 | 1,833 | $5.45 | $10.0K | 1,833 | SEC↗ |
| LENS Presbia PLC | J Other | 2015-08-03 | 2015-08-04 | 8,286 | — | $0 | 19,396 | SEC↗ |
| MDRX ALLSCRIPTS HEALTHCARE SOLU | A Award | 2015-05-29 | 2015-06-01 | 14,215 | — | $0 | 73,120 | SEC↗ |
| LENS Presbia PLC | P Buy | 2015-05-20 | 2015-05-20 | 11,110 | $8.96 | $99.5K | 11,110 | SEC↗ |
| MDRX ALLSCRIPTS HEALTHCARE SOLU | P Buy | 2014-11-11 | 2014-11-12 | 8,849 | $11.29 | $99.9K | 58,905 | SEC↗ |
| MDRX ALLSCRIPTS HEALTHCARE SOLU | A Award | 2014-05-22 | 2014-05-27 | 13,532 | — | $0 | 50,056 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award deriv | 2014-01-24 | 2014-01-29 | 34,224 | — | $0 | 34,224 | SEC↗ |
| OFIX ORTHOFIX INTERNATIONAL N V | A Award deriv | 2013-11-05 | 2013-11-21 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award deriv | 2013-11-04 | 2013-11-06 | 68,448 | — | $0 | 68,448 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy | 2013-05-22 | 2013-05-23 | 2,500 | $0.50 | $1.3K | 10,000 | SEC↗ |
| MDRX ALLSCRIPTS HEALTHCARE SOLU | A Award | 2013-05-21 | 2013-05-23 | 14,225 | — | $0 | 36,524 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy | 2013-05-21 | 2013-05-23 | 7,500 | $0.50 | $3.8K | 7,500 | SEC↗ |
| MDRX ALLSCRIPTS HEALTHCARE SOLU | P Buy | 2013-03-12 | 2013-03-13 | 4,000 | $12.73 | $50.9K | 22,299 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award deriv | 2013-01-30 | 2013-02-01 | 200,000 | — | $0 | 200,000 | SEC↗ |
| MDRX ALLSCRIPTS HEALTHCARE SOLU | A Award | 2012-06-18 | 2012-06-20 | 18,299 | — | $0 | 18,299 | SEC↗ |